1. Home
  2. NGL vs GENB Comparison

NGL vs GENB Comparison

Compare NGL & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NGL ENERGY PARTNERS LP

NGL

NGL ENERGY PARTNERS LP

HOLD

Current Price

$15.63

Market Cap

2.0B

Sector

Utilities

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$15.87

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NGL
GENB
Founded
1940
2018
Country
United States
United States
Employees
569
N/A
Industry
Natural Gas Distribution
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NGL
GENB
Price
$15.63
$15.87
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.20
AVG Volume (30 Days)
228.4K
1.0M
Earning Date
05-28-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.58
P/E Ratio
$366.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.95
$11.00
52 Week High
$18.80
$18.18

Technical Indicators

Market Signals
Indicator
NGL
GENB
Relative Strength Index (RSI) 47.18 55.08
Support Level $15.11 $11.73
Resistance Level $16.70 $16.75
Average True Range (ATR) 0.72 1.21
MACD -0.05 -0.02
Stochastic Oscillator 54.78 49.20

Price Performance

Historical Comparison
NGL
GENB

About NGL NGL ENERGY PARTNERS LP

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: